What is Replicel really worth?Now that this current AS takeover bid has made the rounds the question becomes what is the company in it's current state worth ?
According to this takeover he is pegging the value as virtually worthless. By not offering a traditional buyout even for $.10 per share which amounts to approx. $6,500,000 he is offering nothing with the promise to share 8% of any potential profits in the future.
He is saying the current development of the dermal injector which we were lead to believe was virtually ready to be submitted for FDA approval is worth nothing. We were told this device would change the entire injection process in many dermal categories as well as the injection of stem cells.
RCH-01 had gone through at least 3 trials including Shiseido's trial with modest but encouraging results. This is worth nothing ?
Numerous Patents covering the dermal injector as well as RCH-01, RCT-01, RCS-01. Are they worth nothing ?
I am surpirsied that some Biotech or pharmaceutical companies that have followed Replicel over the years have not come out of the woodwork and made and offer. Even Shiseido could find value in these assets.
What is the company really worth on the open market ?